The pharmacological basis for the treatment of myasthenia gravis.
D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000503:physiopathology; D009469:Neuromuscular Junction / Q000503:physiopathology; D009435:Synaptic Transmission / Q000187:drug effects
D002800:Cholinesterase Inhibitors